Citation: S. Wang-gohrke et J. Chang-claude, Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk, J NAT CANC, 93(21), 2001, pp. 1657-1658
Authors:
Brennan, P
Bogillot, O
Greiser, E
Chang-Claude, J
Wahrendorf, J
Cordier, S
Jockel, KH
Lopez-Abente, G
Tzonou, A
Vineis, P
Donato, F
Hours, M
Serra, C
Bolm-Audorff, U
Schill, W
Kogevinas, M
Boffetta, P
Citation: P. Brennan et al., The contribution of cigarette smoking to bladder cancer in women (pooled European data), CANC CAUSE, 12(5), 2001, pp. 411-417
Authors:
Beckmann, L
Fischer, C
Deck, KG
Nolte, IM
Meerman, GT
Chang-Claude, J
Citation: L. Beckmann et al., Exploring haplotype sharing methods in general and isolated populations todetect gene(s) of a complex genetic trait, GENET EPID, 21, 2001, pp. S554-S559
Authors:
Hofmann, W
Jandrig, B
Classen, E
Nestle-Kraemling, C
Chang-Claude, J
Scherneck, S
Citation: W. Hofmann et al., Identification of a recurrent BRCA1 mutation in German breast-cancer and/or ovarian-cancer families, J CANC RES, 127(3), 2001, pp. 200-202
Authors:
Kropp, S
Becher, H
Nieters, A
Chang-Claude, J
Citation: S. Kropp et al., Low-to-moderate alcohol consumption and breast cancer risk by age 50 yearsamong women in Germany, AM J EPIDEM, 154(7), 2001, pp. 624-634
Authors:
Lakhani, SR
Gusterson, BA
Jacquemier, J
Sloane, JP
Anderson, TJ
van de Vijver, MJ
Venter, D
Freeman, A
Antoniou, A
McGuffog, L
Smyth, E
Steel, CM
Haites, N
Scott, RJ
Goldgar, D
Neuhausen, S
Daly, PA
Ormiston, W
McManus, R
Scherneck, S
Ponder, BAJ
Futreal, PA
Peto, J
Stoppa-Lyonnet, D
Bignon, YJ
Struewing, JP
Bishop, DT
Klijn, JGM
Devilee, P
Cornelisse, CJ
Lasset, C
Lenoir, G
Barkardottir, RB
Egilsson, V
Hamann, U
Chang-Claude, J
Sobol, H
Weber, B
Easton, DF
Stratton, MR
Citation: Sr. Lakhani et al., The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2, CLIN CANC R, 6(3), 2000, pp. 782-789
Authors:
Healey, CS
Dunning, AM
Teare, MD
Chase, D
Parker, L
Burn, J
Chang-Claude, J
Mannermaa, A
Kataja, V
Huntsman, DG
Pharoah, PDP
Luben, RN
Easton, DF
Ponder, BAJ
Citation: Cs. Healey et al., A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability, NAT GENET, 26(3), 2000, pp. 362-364
Authors:
Hofferbert, S
Worringen, U
Backe, J
Ruckert, EM
White, K
Faller, H
Grimm, T
Caffier, H
Chang-Claude, J
Weber, BHF
Citation: S. Hofferbert et al., Simultaneous interdisciplinary counseling in German breast/ovarian cancer families: First experiences with patient perceptions, surveillance behaviorand acceptance of genetic testing, GEN COUNSEL, 11(2), 2000, pp. 127-146
Authors:
Sala, M
Cordier, S
Chang-Claude, J
Donato, F
Escolar-Pujolar, A
Fernandez, F
Gonzalez, CA
Greiser, E
Jockel, KH
Lynge, E
Mannetje, A
Pohlabeln, H
Porru, S
Serra, C
Tzonou, A
Vineis, P
Wahrendorf, J
Boffetta, P
Kogevinas, M
Citation: M. Sala et al., Coffee consumption and bladder cancer in nonsmokers: a pooled analysis of case-control studies in European countries, CANC CAUSE, 11(10), 2000, pp. 925-931
Authors:
Rahman, N
Teare, MD
Seal, S
Renard, H
Mangion, J
Cour, C
Thompson, D
Shugart, Y
Eccles, D
Devilee, P
Meijers, H
Nathanson, KL
Neuhausen, SL
Weber, B
Chang-Claude, J
Easton, DF
Goldgar, D
Stratton, MR
Citation: N. Rahman et al., Absence of evidence for a familial breast cancer susceptibility gene at chromosome 8p12-p22, ONCOGENE, 19(36), 2000, pp. 4170-4173
Authors:
Hodgson, SV
Haites, NE
Caligo, M
Chang-Claude, J
Eccles, D
Evans, G
Moller, P
Morrison, P
Steel, CM
Stoppa-Lyonnet, D
Vasen, H
Citation: Sv. Hodgson et al., A survey of the current clinical facilities for the management of familialcancer in Europe, J MED GENET, 37(8), 2000, pp. 605-607
Authors:
Brennan, P
Bogillot, O
Cordier, S
Greiser, E
Schill, W
Vineis, P
Lopez-Abente, G
Tzonou, A
Chang-Claude, J
Bolm-Audorff, U
Jockel, KH
Donato, F
Serra, C
Wahrendorf, J
Hours, M
T'Mannetje, A
Kogevinas, M
Boffetta, P
Citation: P. Brennan et al., Cigarette smoking and bladder cancer in men: A pooled analysis of 11 case-control studies, INT J CANC, 86(2), 2000, pp. 289-294
Authors:
Wang-Gohrke, S
Chang-Claude, J
Becher, H
Kieback, DG
Runnebaum, IB
Citation: S. Wang-gohrke et al., Progesterone receptor gene polymorphism is associated with decreased risk for breast cancer by age 50, CANCER RES, 60(9), 2000, pp. 2348-2350
Authors:
Carlomagno, F
Chang-Claude, J
Dunning, AM
Ponder, BAJ
Citation: F. Carlomagno et al., Determination of the frequency of the common 657Del5 Nijmegen breakage syndrome mutation in the German population: No association with risk of breastcancer, GENE CHROM, 25(4), 1999, pp. 393-395
Authors:
't Manneje, A
Kogevinas, M
Chang-Claude, J
Cordier, S
Gonzalez, CA
Hours, M
Jockel, KH
Bolm-Audorff, U
Lynge, E
Porru, S
Donato, F
Ranft, U
Serra, C
Tzonou, A
Vineis, P
Wahrendorf, J
Boffetta, P
Citation: A. 'T Manneje et al., Occupation and bladder cancer in European women, CANC CAUSE, 10(3), 1999, pp. 209-217
Authors:
Hodgson, S
Milner, B
Brown, I
Bevilacqua, G
Chang-Claude, J
Eccles, D
Evans, G
Gregory, H
Moller, P
Morrison, P
Steel, M
Stoppa-Lyonnet, D
Vasen, H
Haites, N
Citation: S. Hodgson et al., Cancer genetics services in Europe, DIS MARKER, 15(1-3), 1999, pp. 3-13
Authors:
Vasen, HFA
Haites, NE
Evans, DGR
Steel, CM
Moller, P
Hodgson, S
Eccles, D
Morrison, P
Stoppa-Lyonnet, D
Chang-Claude, J
Caligo, M
Citation: Hfa. Vasen et al., Current policies for surveillance and management in women at risk for breast and ovarian cancer: A survey among 16 European family cancer clinics, DIS MARKER, 15(1-3), 1999, pp. 47-47
Authors:
Chang-Claude, J
Becher, H
Caligo, M
Eccles, D
Evans, G
Haites, N
Hodgson, S
Moller, P
Weber, BHF
Stoppa-Lyonnet, D
Citation: J. Chang-claude et al., Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes, DIS MARKER, 15(1-3), 1999, pp. 53-65
Authors:
Stoppa-Lyonnet, D
Caligo, M
Eccles, D
Evans, DGR
Haites, NE
Hodgson, NS
Moller, P
Morrison, PJ
Steel, CM
Vasen, HFA
Chang-Claude, J
Citation: D. Stoppa-lyonnet et al., Genetic testing for breast cancer predisposition in 1999: which molecular strategy and which family criteria?, DIS MARKER, 15(1-3), 1999, pp. 67-68
Authors:
Steel, M
Smyth, E
Vasen, H
Eccles, D
Evans, G
Moller, P
Hodgson, S
Stoppa-Lyonnet, D
Chang-Claude, J
Caligo, M
Morrison, P
Haites, N
Citation: M. Steel et al., Ethical, social and economic issues in familial breast cancer: a compilation of views from the EC biomed II demonstration project, DIS MARKER, 15(1-3), 1999, pp. 125-131
Authors:
Evans, DGR
Anderson, E
Lalloo, F
Vasen, H
Beckmann, M
Eccles, D
Hodgson, S
Moller, P
Chang-Claude, J
Morrison, P
Stoppa-Lyonnet, D
Steel, M
Haites, N
Citation: Dgr. Evans et al., Utilisation of prophylactic mastectomy in 10 European centers, DIS MARKER, 15(1-3), 1999, pp. 148-151
Authors:
Morrison, PJ
Steel, CM
Vasen, HFA
Eccles, D
Evans, DGR
Moller, P
Hodgson, S
Stoppa-Lyonnet, D
Chang-Claude, J
Caligo, M
Olah, E
Haites, NE
Nevin, NC
Citation: Pj. Morrison et al., Insurance implications for individuals with a high risk of breast and ovarian cancer in Europe, DIS MARKER, 15(1-3), 1999, pp. 159-165